Michael Walter

Title: Innovations by Michael Walter in Gut Inflammation Treatment

Introduction

Michael Walter is an accomplished inventor based in Loma Linda, California. He has made significant contributions to the field of medical science, particularly in the treatment of gut inflammation. With a total of 2 patents, his work focuses on utilizing engineered dendritic cells to induce regulatory T cells.

Latest Patents

Michael Walter's latest patents include a method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation. This innovative approach involves gene-modified, lymphoid-tissue-homing dendritic cells that comprise a 1-alpha-hydroxylase gene and a retinaldehyde dehydrogenase 2 gene. The 1-alpha-hydroxylase gene is expressed to produce a functional 1-alpha-hydroxylase enzyme, while the retinaldehyde dehydrogenase 2 gene is expressed to produce a functional retinaldehyde dehydrogenase 2 enzyme. This method aims to treat one or more inflammation-related conditions or diseases by administering these specialized dendritic cells.

Career Highlights

Michael Walter is affiliated with Loma Linda University, where he continues to advance his research and innovations. His work has garnered attention for its potential to revolutionize treatments for gut-related health issues.

Collaborations

Some of his notable coworkers include Xiaolei Tang and David J Baylink, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Michael Walter's innovative work in the field of gut inflammation treatment showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective therapies that could significantly improve patient outcomes.